Clinical Trial Update: US Inhaled Insulin Dose Titration Study [Phase 3]

View source ↗

Summary

Pfizer's Phase 3 US dose-titration study of inhaled insulin in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED